ChemicalBook >> CAS DataBase List >>7-(tert-butyl)-6-((1-ethyl-1H-1,2,4-triazol-5-yl)methoxy)-3-(2-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazine

7-(tert-butyl)-6-((1-ethyl-1H-1,2,4-triazol-5-yl)methoxy)-3-(2-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazine

CAS No.
252977-51-8
Chemical Name:
7-(tert-butyl)-6-((1-ethyl-1H-1,2,4-triazol-5-yl)methoxy)-3-(2-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazine
Synonyms
TPA 023;TPA 023, 10 mM in DMSO;7-tert-butyl-6-[(2-ethyl-1,2,4-triazol-3-yl)methoxy]-3-(2-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazine;7-(tert-butyl)-6-((1-ethyl-1H-1,2,4-triazol-5-yl)methoxy)-3-(2-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazine;inhibit,γ-Aminobutyric acid Receptor,TPA 023,Inhibitor,Gamma-aminobutyric acid Receptor,TPA-023,GABA Receptor,TPA023;1,2,4-Triazolo[4,3-b]pyridazine, 7-(1,1-dimethylethyl)-6-[(1-ethyl-1H-1,2,4-triazol-5-yl)methoxy]-3-(2-fluorophenyl)-;7-(tert-Butyl)-6-((1-ethyl-1H-1,2,4-triazol-5-yl)methoxy)-3-(2-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazine , TPA 023
CBNumber:
CB83164844
Molecular Formula:
C20H22FN7O
Molecular Weight:
395.43
MDL Number:
MFCD29921350
MOL File:
252977-51-8.mol
MSDS File:
SDS
TDS File:
TDS
Last updated:2026-05-28 05:18:38
Product description Number Pack Size Price
TPA023 ≥98% (HPLC) SML2447 5MG $107
TPA023 ≥98% (HPLC) SML2447 25MG $348
TPA 023 99.75% orb1307656 1mg $110
TPA 023 99.75% orb1307656 5mg $180
TPA 023 99.75% orb1307656 1mlx10mM(inDMSO) $190

7-(tert-butyl)-6-((1-ethyl-1H-1,2,4-triazol-5-yl)methoxy)-3-(2-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazine Properties

Density 1.33±0.1 g/cm3(Predicted)
storage temp. 2-8°C
solubility Soluble in DMSO
pka 2.08±0.10(Predicted)
form Solid
color White to off-white
InChI 1S/C20H22FN7O/c1-5-27-17(22-12-23-27)11-29-19-14(20(2,3)4)10-16-24-25-18(28(16)26-19)13-8-6-7-9-15(13)21/h6-10,12H,5,11H2,1-4H3
InChIKey QKIWQBLNTSQOLY-UHFFFAOYSA-N
SMILES CC(C)(C)C1=CC2=NN=C(C3=CC=CC=C3F)N2N=C1OCC4=NC=NN4CC
FDA UNII 1FI3KTC550
UNSPSC Code 12352200
NACRES NA.77

SAFETY

Risk and Safety Statements

Symbol(GHS)  Exclamation Mark (GHS07)
GHS07
Signal word  Warning
Hazard statements  H302-H315-H319-H335
Precautionary statements  P261-P305+P351+P338
WGK Germany  WGK 3
Storage Class 11 - Combustible Solids

7-(tert-butyl)-6-((1-ethyl-1H-1,2,4-triazol-5-yl)methoxy)-3-(2-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazine price

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich SML2447 TPA023 ≥98% (HPLC) 252977-51-8 5MG $107 2026-04-30 Buy
Sigma-Aldrich SML2447 TPA023 ≥98% (HPLC) 252977-51-8 25MG $348 2026-04-30 Buy
Biorbyt Ltd orb1307656 TPA 023 99.75% 252977-51-8 1mg $110 2026-05-06 Buy
Biorbyt Ltd orb1307656 TPA 023 99.75% 252977-51-8 5mg $180 2026-05-06 Buy
Biorbyt Ltd orb1307656 TPA 023 99.75% 252977-51-8 1mlx10mM(inDMSO) $190 2026-05-06 Buy
Product number Packaging Price Buy
SML2447 5MG $107 Buy
SML2447 25MG $348 Buy
orb1307656 1mg $110 Buy
orb1307656 5mg $180 Buy
orb1307656 1mlx10mM(inDMSO) $190 Buy

7-(tert-butyl)-6-((1-ethyl-1H-1,2,4-triazol-5-yl)methoxy)-3-(2-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazine Chemical Properties,Uses,Production

Uses

TPA 023 is a GABAA α2/α3 subtype-selective agonist, with Ki of 0.19-0.41 nM.

Biological Activity

TPA023 is a highly potent, functionally selective agonist for α2-, α3-, and α5GABAA receptors th at shows zero efficacy at a1GABAA subtypes. TPA023 exhibits anxiolytic and anticonvulsant effects in both animals and humans but lacks sedative effects and abuse potential.

in vivo

TPA023 displays good receptor occupancy, when administered orally to rats. The dose of TPA023 resulting in 50% occupancy of rat brain GABAA receptors is 0.42 mg/kg, with the corresponding plasma concentration being 25 ng/mL. TPA023 is also efficacious in the mouse pentylenetetrazole-induced seizure model, providing full seizure protection at a dose of 10 mg/kg i.p. (84% occupancy), with the ED50 of 0.19-0.41 nM, for protection against tonic convulsions (1.4 mg/kg i.p.) corresponding to around 50% occupancy. TPA023 (3 mg/kg p.o. in 0.5% methyl cellulose) shows anxiolytic-like effect on rats[1]. TPA023 (0.7, 2.0, and 5 mg/kg, p.o.) blocks ketamine's cognitive-impairing ability but does not influence the behavioral symptoms of rhesus monkeys[2].

References

[1] Atack JR. Subtype-selective GABA(A) receptor modulation yields a novel pharmacological profile: the design and development of TPA023. Adv Pharmacol. 2009;57:137-85 DOI:10.1016/S1054-3589(08)57004-9
[2] Castner SA, et al. Reversal of ketamine-induced working memory impairments by the GABAAalpha2/3 agonist TPA023. Biol Psychiatry. 2010 May 15;67(10):998-1001. DOI:10.1016/j.biopsych.2010.01.001

7-(tert-butyl)-6-((1-ethyl-1H-1,2,4-triazol-5-yl)methoxy)-3-(2-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazine Preparation Products And Raw materials

Raw materials

Preparation Products

7-(tert-butyl)-6-((1-ethyl-1H-1,2,4-triazol-5-yl)methoxy)-3-(2-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazine Suppliers

Global( 31)Suppliers
Supplier Tel Email Country ProdList Advantage
TargetMol Chemicals Inc.
+1-781-999-5354; +17819995354 marketing@targetmol.com United States 32466 58
Jilin Chinese Academy of Sciences-yanshen Technology
+undefined18143011203 info@chemextension.com China 42056 58
Shanghai EFE Biological Technology Co., Ltd. 021-65675885 18964387627 info@efebio.com China 9804 58
Fan De(Beijing) Biotechnology Co., Ltd. 15911056312 liming@bio-fount.com China 9729 58
Chengdu Feibai Pharmaceutical Co., Ltd. 028-84641798 18782128315 3302391190@qq.com China 5267 55
Xi'an Minze Pharmaceutical Technology Co., Ltd 13981836672 2560370848@qq.com China 2807 58
ChemeGen(Shanghai) Biotechnology Co.,Ltd. 18818260767 sales@chemegen.com China 11218 58
cjbscvictory 13348960310 13348960310 3003867561@qq.com China 10336 58
Hubei Co-prosperity Medicine Technonlogy Co., Ltd 2383948258 19172820304 2383948258@qq.com China 12987 58
Beijing Jin Ming Biotechnology Co., Ltd. 010-60605840 15801484223; psaitong@jm-bio.com China 29757 58

View Lastest Price from 7-(tert-butyl)-6-((1-ethyl-1H-1,2,4-triazol-5-yl)methoxy)-3-(2-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazine manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
TPA 023 pictures 2026-05-11 TPA 023
252977-51-8
$67.00-196.00 99.75% 10g TargetMol Chemicals Inc.
  • TPA 023 pictures
  • TPA 023
    252977-51-8
  • $67.00-196.00
  • 99.75%
  • TargetMol Chemicals Inc.

7-(tert-butyl)-6-((1-ethyl-1H-1,2,4-triazol-5-yl)methoxy)-3-(2-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazine Spectrum

7-tert-butyl-6-[(2-ethyl-1,2,4-triazol-3-yl)methoxy]-3-(2-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazine 7-(tert-butyl)-6-((1-ethyl-1H-1,2,4-triazol-5-yl)methoxy)-3-(2-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazine 1,2,4-Triazolo[4,3-b]pyridazine, 7-(1,1-dimethylethyl)-6-[(1-ethyl-1H-1,2,4-triazol-5-yl)methoxy]-3-(2-fluorophenyl)- inhibit,γ-Aminobutyric acid Receptor,TPA 023,Inhibitor,Gamma-aminobutyric acid Receptor,TPA-023,GABA Receptor,TPA023 TPA 023, 10 mM in DMSO 7-(tert-Butyl)-6-((1-ethyl-1H-1,2,4-triazol-5-yl)methoxy)-3-(2-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazine , TPA 023 TPA 023 252977-51-8 C20H22FN7O